2017
- NICE's affordability proposals: Legal challenge looms PE Speaks 18 Jul 2017
- ABPI challenges NICE on unpopular affordability changes PE Speaks 18 Jul 2017
- ICER's evolving value framework PE Speaks 14 Jul 2017
- Value frameworks in the US: Not an echo chamber PE Speaks 13 Jul 2017
- Refining value in pharma PE Speaks 12 Jul 2017
- A hard or soft Brexit? More uncertainty for the life sciences industry PE Speaks 11 Jun 2017
- UK political parties set out pharma stalls ahead of June election PE Speaks 22 May 2017
- England updates "Innovation Scorecard" PE Speaks 18 Apr 2017
- Affordability: An unpopular NICE and NHSE approach PE Speaks 16 Mar 2017
- Playing NICE with the pharma industry PE Speaks 23 Feb 2017
- Right care for health: Implications for pharma PE Speaks 10 Jan 2017
2016
- England to selectively accelerate innovation PE Speaks 27 Oct 2016
- Deal or delay: NICE's new negotiating chip PE Speaks 20 Oct 2016
- A tale of two pricing schemes PE Speaks 20 Sept 2016
- NICE sets out proposed technology assessment fees PE Speaks 7 Sept 2016
- Mini NICEs for England? PE Speaks 1 Sept 2016
- Time for a rethink on managed access spend? PE Speaks 5 Aug 2016
- The 2016 Cancer Drugs Fund in England PE Speaks 29 Jul 2016
- Dappled sunshine in the UK: Disclosure UK Database Launched PE Speaks 7 Jul 2016
- Brexit Blues: What now for UK life sciences? PE Speaks 27 Jun 2016
- What's the future of the UK's PPRS? PE Speaks 1 Jun 2016
- NICE lite? PE Speaks 18 May 2016
- UK Industry likely to pay for NICE Technology Assessments PE Speaks 21 Mar 2016
- Stakeholders react to England's Cancer Drug Fund proposals PE Speaks 17 Feb 2016
- UK NHS: Evaluating Innovation, Health and Wealth PE Speaks 14 Jan 2016
- A 'new' Cancer Drugs Fund for England PE Speaks 25 Nov 2015
- The UK's Accelerated Access Review: Time to dust off old reports? 10 Nov 2015
- High hopes for England's Accelerated Access Review PE Speaks 6 Oct 2015
- England's Cancer Drugs Fund: Will patients pay the price for being at the back of the line? PE Speaks 15 Sept 2015
- NICE proposes Office of Market Access PE Speaks 20 May 2015
- What does the UK's 'new' Government mean for industry? PE Speaks 18 May 2015
- New European Guidelines tackle controversial HTA components PE Speaks 11 May 2015
- The UK elections's hot healthcare topics PE Speaks 16 Apr 2015
- The NHS's meningitis B vaccine deal with GSK: A slow step in the right direction PE Speaks 6 Apr 2015
- The NICE threshold debate heats up PE Speaks 2 Mar 2015
- England's Cancer Drug Fund conundrum PE Speaks 13 Jan 2015
2014
- Tougher times ahead under UK PPRS PE Speaks 16 Dec 2014
- UK: Saatchi Innovation Bill still divisive PE Speaks 30 Nov 2014
- New Scottish Medicines Fund boosted by UK PPRS PE Speaks 28 Oct 2014
- How do you solve a problem like England's Cancer Drugs Fund? PE Speaks 27 Oct 2014
- US company awarded UK's first "Promising Innovative Medicine" designation PE Speaks 30 Sept 2014
- UK postpones decision on Value Based Assessment - Again PE Speaks 29 Sept 2014
- PPRS payments now worth £150m in the UK PE Speaks 18 Sept 2014
- Controversial Cancer Fund boosted - but what's the long-term plan? PE Speaks 2 Sept 2014
- Value Based Assessment in the UK: The patient view PE Speaks 14 Jul 2014
- Industry challenged: "Do more for teenagers with cancer" PE Speaks 8 Jul 2014
- Value Based Assessment in the UK: The industry view PE Speaks 7 Jul 2014
- Show me the money: First new PPRS payments in UK PE Speaks 7 Jul 2014
- Sanofi responds to UK's Value Based Assessment plans PE Speaks 4 Jul 2014
- UK: Patient group sets out orphan drug charter 20 May 2014
- England: Ignoring NICE guidelines can be unlawful PE Speaks 1 May 2014
- Pursuing the 'real' cost effectiveness threshold in England PE Speaks 25 Apr 2014
- UK: Lord Saatchi's Innovation Bill divides healthcare community PE Speaks 9 Apr 2014
- UK: Further steps towards value based assessment PE Speaks 31 Mar 2014
- UK drug pricing: An ICER of zero? PE Speaks 19 Mar 2014
- UK: Is Value Based Assessment the new Value Based Pricing? PE Speaks 27 Jan 2014
- England: Is the Cancer Drugs Fund running out of money? PE Speaks 15 Jan 2014
2013
- Europe: EMA and EUnetHTA agree three year work plan PE Speaks 10 Dec 2013
- UK Plan for Rare Diseases: Little focus on access to medicines PE Speaks 2 Dec 2013
- What does the UK's new PPRS mean for Value Based Pricing? 20 Nov 2013
- The PPRS is dead: Long live the PPRS! PE Speaks 6 Nov 2013
- Bid to improve access to medicines in Scotland PE Speaks 9 Oct 2013
- Big pharma welcomes extension to England's Cancer Drug Fund, critics unconvinced PE Speaks 8 Oct 2013
- The Cancer Drugs Fund under NHS England: Q1 results PE Speaks 27 Aug 2013
- NICE's looming Value Based Pricing challenges PE Speaks 29 Jul 2013
- England's latest Innovation Scorecard: A patchy picture PE Speaks 17 Jun 2013
- UK Value Based Pricing: Will Scotland take a different approach? PE Speaks 10 Jun 2013
- The UK's new "revolutionary" Medicines Optimisation Plan PE Speaks 21 May 2013
- Tough times ahead for new medicines under NHS England PE Speaks 22 Apr 2013
- England's Cancer Drug Fund: An acid test for Value Based Pricing PE Speaks 12 Apr 2013
